1-3 of 3
Cristina Rodriguez, MD
Close
Sort by
Journal Articles

Development of a Prognostic Scoring System for Secondary Acute Myeloid Leukemia (sAML) Arising from Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Sanjay R. Mohan, MD, Paul Elson, ScD, Cristina Rodriguez, MD, Rachid Baz, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Anjali Advani, MD, Ed Copelan, MD, Lukasz P. Gondek, MD, Jaroslaw P. Maciejewski, MD, PhD, Mikkael A. Sekeres, MD, MS
Journal: Blood
Blood (2008) 112 (11): 921.
https://doi.org/10.1182/blood.V112.11.921.921
Published: 2008
Journal Articles

Comparison of Prognostic Factors and Outcomes of Patients with Secondary Acute Myeloid Leukemia (AML) Following Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Sanjay Mohan, MD, Paul Elson, ScD, Cristina Rodriguez, MD, Rachid Baz, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Anjali Advani, MD, Jaroslaw P. Maciejewski, MD, PhD, Edward Copelan, MD, Mikkael A. Sekeres, MD
Journal: Blood
Blood (2007) 110 (11): 4292.
https://doi.org/10.1182/blood.V110.11.4292.4292
Published: 2007
Journal Articles

c-Kit (CD117) Expression Is a Poor Prognostic Factor for Relapse and Overall Survival in Patients with Newly Diagnosed AML.

Cristina Rodriguez, MD, Tao Jin, MS, Rony Abou Jawde, MD, Wael Saber, MD, Rachid Baz, MD, Eric His, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Anjali Advani, MD
Journal: Blood
Blood (2006) 108 (11): 4510.
https://doi.org/10.1182/blood.V108.11.4510.4510
Published: 2006